RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells

Molecular Carcinogenesis
Anand VenugopalShrikant Anant

Abstract

Colorectal cancer (CRC) is the second leading cause of cancer deaths in the United States. It arises from loss of intestinal epithelial homeostasis and hyperproliferation of the crypt epithelium. In order to further understand the pathogenesis of CRC it is important to further understand the factors regulating intestinal epithelial proliferation and more specifically, regulation of the intestinal epithelial stem cell compartment. Here, we investigated the role of the RNA binding protein RBM3 in stem cell homeostasis in colorectal cancers. Using a doxycycline (Dox) inducible RBM3 overexpressing cell lines HCT 116 and DLD-1, we measured changes in side population (SP) cells that have high xenobiotic efflux capacity and increased capacity for self-renewal. In both cell lines, RBM3 induction showed significant increases in the percentage of side population cells. Additionally, we observed increases in spheroid formation and in cells expressing DCLK1, LGR5 and CD44(Hi) . As the Wnt/β-catenin signaling pathway is important for both physiologic and cancer stem cells, we next investigated the effects of RBM3 overexpression on β-catenin activity. RBM3 overexpression increased levels of nuclear β-catenin as well as TCF/LEF transcriptiona...Continue Reading

References

Jun 1, 1990·Cell·E R Fearon, B Vogelstein
Feb 2, 1996·The Journal of Biological Chemistry·C KnallG L Johnson
Dec 1, 1995·Human Molecular Genetics·J M DerryU Francke
Apr 1, 1996·The Journal of Experimental Medicine·M A GoodellR C Mulligan
Jan 1, 1997·Cancer Chemotherapy and Pharmacology·B I SikicG Chen
Sep 4, 1998·Science·T C HeK W Kinzler
Feb 23, 1999·The American Journal of Pathology·V J WielengaS T Pals
Sep 10, 2002·Human Molecular Genetics·Hiroko KitaKikuya Kato
May 21, 2003·Genes & Development·Gabriela DontuMax S Wicha
Jan 1, 2004·Chemistry & Biology·Laurent MeijerPaul Greengard
Sep 24, 2004·Proceedings of the National Academy of Sciences of the United States of America·C Hirschmann-JaxM K Brenner
Jun 1, 2005·Experimental Cell Research·Hideyuki OkanoTakao Imai
Mar 7, 2006·Nature Reviews. Drug Discovery·Gergely SzakácsMichael M Gottesman
Nov 24, 2006·Nature·Lucia Ricci-VitianiRuggero De Maria
Jan 16, 2007·Nature Cell Biology·Abderrahmane KaidiChristos Paraskeva
Jan 26, 2007·Nature Reviews. Cancer·Robert T Dorsam, J Silvio Gutkind
Feb 20, 2007·Current Opinion in Cell Biology·Riccardo Fodde, Thomas Brabletz
Mar 15, 2008·Cancer Research·Dharmalingam SubramaniamShrikant Anant
Apr 25, 2008·Nature Reviews. Cancer·Alexandra Klaus, Walter Birchmeier
Sep 12, 2008·Nature Reviews. Cancer·Jane E Visvader, Geoffrey J Lindeman
Nov 26, 2008·The Journal of Pathology·S BrabletzT Brabletz
Dec 19, 2008·Nature·Nick BarkerHans Clevers
Jan 28, 2009·Nature Reviews. Immunology·Antonio UccelliVito Pistoia
Mar 12, 2009·Journal of Cellular Biochemistry·Yu ZengRobert H Getzenberg
Sep 8, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Annika JögiKarin Jirström
Aug 10, 2010·Molecular Cancer·Shailender S KanwarAdhip P N Majumdar
Sep 21, 2010·Nature Cell Biology·Jolly MazumdarM Celeste Simon
Apr 30, 2011·Neurobiology of Disease·Sophorn ChipSven Wellmann
May 20, 2011·American Journal of Physiology. Cell Physiology·Amy L FerryEsther E Dupont-Versteegden
Dec 4, 2012·Nature Genetics·Yuki NakanishiTsutomu Chiba
Feb 23, 2013·BMJ Case Reports·Peter Ng

❮ Previous
Next ❯

Citations

May 6, 2016·Cellular and Molecular Life Sciences : CMLS·Xinzhou ZhuSven Wellmann
Dec 9, 2016·Inflammatory Bowel Diseases·Toshiharu SakuraiMasatoshi Kudo
Dec 7, 2018·American Journal of Physiology. Gastrointestinal and Liver Physiology·Louis R ParhamKathryn E Hamilton
Jan 24, 2018·Scientific Reports·Shweta DuggalAjay Kumar
Mar 2, 2019·Stress : the International Journal on the Biology of Stress·Hongzhao ShiShize Li
Jun 16, 2017·Journal of Molecular Neuroscience : MN·Eleni Merkouri PapadimaAlessio Squassina
Aug 24, 2019·Frontiers in Molecular Biosciences·Jennyfer M García-CárdenasCésar Paz-Y-Miño
Dec 22, 2019·Cells·Xueqiao JiaoLixia Xiong
Dec 3, 2016·International Journal of Oncology·Yong ZhangXue-Yun Zhong
Feb 6, 2019·International Journal of Oncology·Ping ChenZhenling Ji
Feb 23, 2019·World Journal of Gastrointestinal Oncology·Noémie LegrandCyril Sobolewski
Aug 21, 2020·Communications Biology·Amber N HabowskiMarian L Waterman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adherens Junctions

An adherens junction is defined as a cell junction whose cytoplasmic face is linked to the actin cytoskeleton. They can appear as bands encircling the cell (zonula adherens) or as spots of attachment to the extracellular matrix (adhesion plaques). Adherens junctions uniquely disassemble in uterine epithelial cells to allow the blastocyst to penetrate between epithelial cells. Discover the latest research on adherens junctions here.

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.